Provided by Tiger Fintech (Singapore) Pte. Ltd.

Macrogenics

1.21
+0.02001.68%
Post-market: 1.210.00000.00%19:58 EDT
Volume:716.59K
Turnover:877.76K
Market Cap:76.34M
PE:-1.36
High:1.27
Open:1.23
Low:1.20
Close:1.19
Loading ...

MacroGenics (MGNX) Receives a Hold from Stifel Nicolaus

TIPRANKS
·
11 Jun

MacroGenics (MGNX) Gets a Hold from Citizens JMP

TIPRANKS
·
11 Jun

MacroGenics Shares Rise 19.8% After Partnership With Sagard Healthcare Partners for Zynyz Royalty

THOMSON REUTERS
·
10 Jun

BUZZ-U.S. STOCKS ON THE MOVE-United Natural Foods, Insmed, MacroGenics

Reuters
·
10 Jun

MacroGenics Shares Jump 20% Premarket After Partnership With Sagard Healthcare Partners for Zynyz® Royalty

THOMSON REUTERS
·
10 Jun

MacroGenics Inc. Enters Partnership with Sagard Healthcare Partners for ZYNYZ® Royalty Agreement

Reuters
·
10 Jun

MacroGenics Inc - Cash Runway Extended Through First Half of 2027

THOMSON REUTERS
·
10 Jun

MacroGenics Inc - Receives $70 Mln Upfront Payment From Sagard

THOMSON REUTERS
·
10 Jun

MacroGenics and Sagard Healthcare Partners Enter Into Zynyz® Royalty Purchase Agreement

THOMSON REUTERS
·
10 Jun

Macrogenics Is Maintained at Neutral by B. Riley Securities

Dow Jones
·
20 May

B. Riley Cuts Price Target on MacroGenics to $3 From $5, Keeps Neutral Rating

MT Newswires Live
·
20 May

Macrogenics Is Maintained at Overweight by Barclays

Dow Jones
·
14 May

MacroGenics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Macrogenics Q1 EPS $(0.65) Beats $(0.76) Estimate, Sales $13.19M Beat $6.17M Estimate

Benzinga
·
14 May

MacroGenics Inc. Reports Q1 2025 Revenue Increase to $13.2M, Net Loss Narrows to $41M

Reuters
·
14 May

BRIEF-MacroGenics Q1 Net Income USD -41 Million

Reuters
·
14 May

MacroGenics Inc: Cash Runway Into Second Half of 2026

THOMSON REUTERS
·
14 May

MacroGenics Inc expected to post a loss of 78 cents a share - Earnings Preview

Reuters
·
10 May

MacroGenics Inc expected to post a loss of 78 cents a share - Earnings Preview

Reuters
·
05 May

4 Medical Product Stocks to Buy From a Challenging Industry

Zacks
·
17 Apr